Substance Use Disorder (SUD) presents a significant global health concern. Resilience plays a crucial role in aiding recovery from mental disorders, and its importance in improving SUD treatment outcomes is increasingly recognized. Accurately predicting relapse risk can lead to personalized care, optimizing recovery outcomes. Therefore, culturally validated tools to measure resilience and relapse risk are essential prerequisites. To assess the validity and reliability of the Arabic translations of the Connor and Davidson Resilience Scale (A-CD-RISC-25) and the Stimulant Relapse Risk Scale (A-SRRS). The correlation between A-CD-RISC-25 and A-SRRS has also been explored. Translation from English to Arabic involved two bilingual mental health professionals. Adjustments were made during back-translation for consistency. 286 adults with SUD participated through consecutive sampling. Internal consistency was assessed using Cronbach’s alpha, and validity was evaluated through item-to-total correlations, item-item correlations, and Spearman’s correlations. Additional analyses using Mann-Whitney U and Kruskal-Wallis tests examined associations with demographic and clinical variables. Cronbach’s alpha values for A-CD-RISC-25 and A-SRRS were 0.904 and 0.901, respectively. For the A-CD-RISC-25, item-to-total correlations ranged from 0.19 to 0.62, indicating moderate to strong links with resilience. Item 20 showed a weaker correlation, and its removal increased Cronbach’s Alpha to 0.908. The overall internal consistency was excellent (Cronbach’s Alpha 0.898–0.908). Subscales showed strong consistency for Subscale 1 (0.804–0.827), moderate for Subscales 2 and 3, and weaker for Subscale 5. The A-SRRS showed good reliability, with item-to-total correlations ranging from 0.116 to 0.696, though Items 14 and 17 had negative correlations. Subscales 1–4 were reliable, while Subscale 5 showed poor reliability. Arabic translations of the CD-RISC-25 and SRRS are valid, consistent, and correlate positively, underlining their combined utility in assessing resilience and predicting relapse in SUD patients in the Arabic population.
Mhaidat et al. (Sun,) studied this question.